Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209917) titled 'Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India' on Sept. 29.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Care Provider, Outcomes Assessor).
Primary Sponsor: University of California, Irvine
Condition:
Cervical Cancer
HPV Infection
HIV Infection
Intervention:
Behavioral: ASHA-Health HPV Intervention
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 1, 2025
Target Sample Size: 420
To know more, visit https://clinicaltria...